Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Ekmasonid vs Uceris (Budesonide) in Healthy Volunteers
NCT04854538Phase 1Completed
- Sponsor
- Genuine Research Center
- Start
- Sep 2020
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Budicort in ulcerative colitis (UC) (3 arms), sponsored by Genuine Research Center. Primary endpoints: Maximum Plasma Concentration, Area Under the Curve from time 0 to last measurable concentration and 1 more. Started Sep 2020; status: completed.
02
Drugs
Budicort
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT04854538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04854538.